Phase 1 Study of SPT-2101 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere's Disease

Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2021
This article has no abstract
Epistemonikos ID: cc9324be936ba9919619c542d930ded0519d62ca
First added on: Mar 18, 2025